P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease (Q87447619)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24631773%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24631773%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

7

Philippe Pibarot

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24631773%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Diala El Husseini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24631773%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Marie-Chloé Boulanger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24631773%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Ablajan Mahmut

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24631773%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Rihab Bouchareb

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24631773%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Marie-Hélène Laflamme

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24631773%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Dominique Fournier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24631773%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Yohan Bossé

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24631773%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Patrick Mathieu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24631773%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

11 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24631773%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular and Cellular Cardiology

10 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24631773%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24631773%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

146-156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24631773%20AND%20SRC:MED&resulttype=core&format=json

The 'valvulo-metabolic' risk in calcific aortic valve disease

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Inflammation is associated with the remodeling of calcific aortic valve disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Gp130 and the interleukin-6 family of cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Angiotensin receptor blockers are associated with reduced fibrosis and interleukin-6 expression in calcific aortic valve disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

ATP acts as a survival signal and prevents the mineralization of aortic valve.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

High expression of the Pi-transporter SLC20A1/Pit1 in calcific aortic valve disease promotes mineralization through regulation of Akt-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Refining molecular pathways leading to calcific aortic valve stenosis by studying gene expression profile of normal and calcified stenotic human aortic valves.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Significance analysis of microarrays applied to the ionizing radiation response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Interleukin-6 and its receptor: a paradigm for cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Nucleotide pyrophosphatases/phosphodiesterases on the move

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Pharmacology of ectonucleotidases: relevance for the treatment of cardiovascular disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Protective role of P2Y2 receptor against lung infection induced by pneumonia virus of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

IkappaB kinases: key regulators of the NF-kappaB pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Regulation of NF-κB by ubiquitination and degradation of the IκBs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

The phosphatidylinositol 3-kinase/Akt pathway negatively regulates Nod2-mediated NF-kappaB pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Inflammatory cytokines promote mesenchymal transformation in embryonic and adult valve endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Aortic valve calcification: association with bone mineral density and cardiovascular risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Tocilizumab for the treatment of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

Inhibition of ectonucleotidase with ARL67156 prevents the development of calcific aortic valve disease in warfarin-treated rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.02.014

10.1016/J.YJMCC.2014.02.014

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24631773%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference